Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ELVN compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
ELVN
Enliven Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
ELVN
Enliven Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ELVN
5
—
CoreRx
unlisted
supplier
—
Hande Sciences
unlisted
supplier
—
Latitude Pharmaceuticals
unlisted
supplier
—
Pharmaron
unlisted
supplier
1 more · ELVN chain
›
Shared
0
No shared counterparties.
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
25 more · LLY chain
›
ELVN
Enliven Therapeutics, Inc.
Change
44.77
▼
−5.24%
· post 44.78
Mkt cap
$3.5B
Revenue
—
Revenue
—
LLY
ELI Lilly & Co
Change
1,371.32
▼
−3.29%
· post 1,363.77
Closed
Nov 5 '26
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Closed
Nov 5 '26
ELVN
Enliven Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
44.77
▼
−5.24%
post 44.78
Price
1,371.32
▼
−3.29%
post 1,363.77
$3.5B
Mkt cap
$1.3T
—
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
ELVN
44.77
▼
−5.24%
vs
LLY
1,371.32
▼
−3.29%
Closed
Nov 5 '26